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Air pollution is associated with preterm birth (PTB), potentially via inflammation. We recently showed the
mixture benzene, toluene, ethylbenzene, and xylene (BTEX) is associated with PTB. We examined if ambient
BTEX exposure is associated with mid-pregnancy inflammation in a sample of 140 African-American women
residing in Detroit, Michigan. The Geospatial Determinants of Health Outcomes Consortium study collected
outdoor air pollution measurements in Detroit; these data were coupled with Michigan Air Sampling Network
measurements to develop monthly BTEX concentration estimates at a spatial density of 300 m2. First trimester
and mid-pregnancy BTEX exposure estimates were assigned to maternal address. Mid-pregnancy (mean
21.3 ± 3.7 weeks gestation) inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin [IL]-6, IL10, IL-1β, and tumor necrosis factor-α) were measured with enzyme immunoassays. After covariate adjustment,
for every 1-unit increase in first trimester BTEX, there was an expected mean increase in log-transformed IL-1β of
0.05 ± 0.02 units (P = 0.014) and an expected mean increase in log-transformed tumor necrosis factor-α of
0.07 ± 0.02 units (P = 0.006). Similarly, for every 1-unit increase in mid-pregnancy BTEX, there was a mean
increase in log IL-1β of 0.06 ± 0.03 units (P = 0.027). There was no association of either first trimester or midpregnancy BTEX with high-sensitivity C-reactive protein, IL-10, or IL-6 (all P > 0.05). Ambient BTEX exposure is
associated with inflammation in mid-pregnancy in African-American women. Future studies examining if
inflammation mediates associations between BTEX exposure and PTB are needed.

1. Introduction
Air pollutants impact birth outcomes (Nieuwenhuijsen et al., 2013;
Guo et al., 2019) including preterm birth (PTB). We (Cassidy-Bushrow

et al., 2020) and others (Llop et al., 2010; Santos and Nascimento, 2019;
Serrano-Lomelin et al., 2019) found exposure to the mixture benzene,
toluene, ethylbenzene, and xylene (BTEX) or to individual BTEX com
ponents in ambient air is associated with PTB. BTEX compounds are

Abbreviations: BMA, N-acetyl-S-benzyl-L-cysteine; BMI, body mass index; BTEX, benzene, toluene, ethylbenzene, and xylene; GeoDHOC, Geospatial Determinants
of Health Outcomes Consortium; GulF, Gulf Long-Term Follow-up study; HFHS, Henry Ford Health System; hs-CRP, high-sensitivity C-reactive protein; IL, inter
leukin; LMP, last menstrual period; LOD, limit of detection; NK, Natural Killer; PMA, N-acetyl-S-phenyl-L-cysteine; PTB, preterm birth; SPE, solid phase extraction;
TNF, tumor necrosis factor.
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volatile organics in the atmosphere originating primarily from motor
vehicle exhaust and local stationary sources (Brunekreef and Holgate,
2002; Hinwood et al., 2007). While a small body of evidence links
benzene with measures of immune function and inflammation (Baiz
et al., 2011; Minciullo et al., 2014), to our knowledge no studies have
specifically examined if ambient BTEX exposure is associated with
altered inflammation in pregnancy.
Successful pregnancy requires tight control of both the maternal and
fetal immune system (Mor et al., 2011, 2017). Dysregulation of maternal
and fetal immune systems is linked to adverse pregnancy outcomes
(Christiaens et al., 2008; Chatterjee et al., 2014; Ragsdale et al., 2019).
For example, inflammation is a critical mediator of parturition; how
ever, when triggered earlier, such as in cases of infection, the resulting
inflammatory cascade can induce PTB (Nadeau et al., 2016). Inflam
matory processes may impact associations between air pollutants, such
as BTEX, and PTB (Vadillo-Ortega et al., 2014). Adverse health effects
from benzene may be due to chronic inflammation and an
immune-mediated response (Gross and Paustenbach, 2018). Minciullo
et al. (2014) summarized evidence of altered cytokine expression due to
benzene, which included tumor necrosis factor-α (TNF-α), Interleukin
(IL)-1β, IL-2, and IL-10. However, there is limited information on how
prenatal BTEX exposure impacts the maternal immune system.
Detroit, Michigan has one of the highest PTB rates in the United
States, with African-American women in Michigan having a 54 % higher
PTB rate than non-African American women (March of Dimes, 2018;
Martin et al., 2019). African-American women are also more likely to be
exposed to environmental toxicants (Burris et al., 2011; Burris and
Hacker, 2017). Thus, the goal of this study was to examine if ambient
BTEX exposure estimated through high resolution spatial monitoring
(Miller et al., 2010; Lemke et al., 2014; O’Leary and Lemke, 2014; Miller
et al., 2019) was associated with inflammatory biomarkers in the second
trimester of pregnancy in African-American women in Detroit (Cassi
dy-Bushrow et al., 2012; Bobbitt et al., 2015).

December 2010 (O’Leary and Lemke, 2014).
Maternal residential address at the time of inflammatory biomarker
measurement was self-reported and used to estimate ambient BTEX
exposures. We defined the bounds of exposure by last menstrual period
(LMP) date (lower bound) and date of inflammatory biomarker measure
(upper bound). Exposures for pregnancies with a LMP date on or before
the 15th of each month were considered to begin in that month while
exposures for pregnancies with a LMP date after the 15th of a month
were considered to begin the following month (Cassidy-Bushrow et al.,
2020). We calculated mid-pregnancy BTEX exposure by averaging the
monthly BTEX exposure estimates for each month of the pregnancy
through the time of inflammatory biomarker measurement. A similar
approach was used to estimate average first trimester BTEX exposure.
For visualization purposes, first trimester and mid-pregnancy BTEX
exposure was dichotomized at the median (7.30 μg/m3 and 7.98 μg/m3
for first trimester and mid-pregnancy BTEX, respectively). The relative
fraction of individual BTEX components observed in the GeoDHOC and
Michigan Air Sampling Network measurements are presented in Sup
plementary Table S1.
2.3. Mid-pregnancy inflammatory biomarkers

2. Materials and methods

All assays were performed with serum obtained in the second
trimester (stored at -80◦ ) (Cassidy-Bushrow et al., 2012).
High-sensitivity C-reactive protein (hs-CRP; mg/L) was measured by
enzyme immunoassay (BioCheck, Inc., Foster City, CA). The limit of
detection (LOD) was 0.1 mg/L. IL-1β, IL-6, IL-10 and TNF-α (pg/mL)
were assayed on a Bio-Plex 200 System using Bio-Plex Pro Cytokine
Assay custom 4-plex kits (Bio-Rad, Hercules, CA); the LOD was 0.6, 2.6,
0.3, and 6.0 pg/mL, respectively. Women with inflammatory bio
markers < LOD were set to the mid-point between 0 and LOD (Alper
et al., 2010). We calculated the IL-6 to IL-10 ratio as a measure of the
pro-inflammatory to anti-inflammatory milieu and the IL-10 to TNF-α
ratio as a measure of the anti-inflammatory to pro-inflammatory milieu
(Taniguchi et al., 1999; Kaislasuo et al., 2020).

2.1. Study population

2.4. Pilot analysis: BTEX metabolite measurement

The study population has been described previously (Cassidy-Bush
row et al., 2012; Bobbitt et al., 2015). Pregnant African-American
women who were patients in the Henry Ford Health System (HFHS),
ages 18–44 years, and in the second trimester of pregnancy (~13− 28
weeks gestation) were eligible. Recruitment spanned February 2009 to
June 2010. Written informed consent was obtained. Study protocols
were approved by Institutional Review Boards at HFHS and Wayne State
University.
A total of 203 women completed the study; 142 resided in the
boundaries of air pollution measurement (i.e., within Detroit as
described below). Two women without inflammatory biomarker mea
surements were excluded. Our final analytic sample size was 140
women.

Our ambient BTEX exposure assignments reflect estimated expo
sures, which may be subject to misclassification bias (Bove et al., 2002).
We measured two BTEX metabolites in maternal plasma: the benzene
metabolite N-acetyl-S-phenyl-L-cysteine (PMA) and the toluene metab
olite N-acetyl-S-benzyl-L-cysteine (BMA) in a subset of 25 women. An
online concentration high-performance liquid chromatography/elec
trospray ionization tandem mass spectrometry method was utilized;
online concentration provides a high throughput workflow that provides
economic and quick response time advantages compared to solid phase
extraction (SPE) performed by manual or automated technologies. This
concentrating step provides two orders of magnitude of method sensi
tivity as compared to SPE methods. The metabolites are separated by
reversed phase chromatography and quantified by multiple reaction
monitoring. For both metabolites, the LOD was 3.0 parts per trillion;
data were reported as (1) a quantitative level, (2) an assignment of being
detectable but under the limit of quantification, or (3) as undetectable.
For every 10 samples that were analyzed, a duplicate and spiked (plasma
fortified with a known concentration of the standard) sample were run.
The percent recovery for spiked samples was between 73 %–124 % for
PMA and 97 %–119 % for BMA. The percent relative standard deviation
for duplicate samples run was 12 %–28 % for BMA (none of the duplicate
samples contained PMA). Because of the large number that were unde
tectable (68 % PMA and 16 % BMA), for analysis women were catego
rized as having detectable vs. undetectable metabolite levels for each
metabolite.

2.2. BTEX estimation and exposure assignment
The Geospatial Determinants of Health Outcomes Consortium
(GeoDHOC) performed high resolution spatial monitoring of air pollu
tion in Detroit at 68 sites during September 5–20, 2008 and 86 sites
during May 29-June 13, 2009 (Miller et al., 2010; Lemke et al., 2014;
O’Leary and Lemke, 2014; Miller et al., 2019). During the sampling
period, passive samplers measured BTEX concentrations at a spatial
sampling density of ~5 km2 per sample. Ordinary kriging was used to
model total BTEX concentration at a geospatial resolution approxi
mating a city block scale (i.e., 300m × 300m); these models were
combined with temporally detailed 3-year air contaminant time series
data from the Michigan Air Sampling Network to generate monthly
BTEX concentration maps for Detroit covering January 2008 through
2
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2.5. Covariate assessment

Table 1
Descriptive characteristics of the study population and a comparison of women
included and excluded from the analytic sample.

Participants self-reported date of birth, marital status, education,
employment status, cigarette smoking, alcohol use, and pre-pregnancy
height and weight. Pre-pregnancy body mass index (BMI) was calcu
lated as weight (kg)/height (m2). Parity was abstracted from the medical
record.
2.6. Statistical analysis
SAS version 9.4 (SAS Institute, Cary, NC) was used for all analyses.
Each inflammatory biomarker, after log-transformation to reduce nonnormality, was examined separately. We compared women included
and excluded from the analysis by demographic characteristics and in
flammatory biomarker variables using an independent t-test for con
tinous variables and a chi-square test for categorical variables.
Linear regression models were used to examine the association of
BTEX exposure (first trimester and mid-pregnancy, separately) with
each inflammatory biomarker/ratio. The 140 women resided in 127
unique census tracts, thus there was minimal clustering and models did
not account for spatial clustering. Models were fit unadjusted, and then
adjusted for potential confounding variables previously identified as
being associated with ≥2 of the inflammatory biomarkers (maternal age,
pre-pregnancy BMI, and education) (Cassidy-Bushrow et al., 2012).
Although all inflammatory biomarkers were measured in the second
trimester, the gestational age at the time of measurement varied from
13.1–27.9 weeks; inflammatory biomarker levels change over preg
nancy (Ferguson et al., 2014), thus we refit models additionally adjusted
for gestational age at time of measurement.
Benzene (PMA) and toluene (BMA) metabolites were available for 25
women. A Wilcoxon rank sum test was used to compare ambient BTEX in
both the first trimester and mid-pregnancy and each inflammatory
biomarker by whether or not each metabolite was detectable.

Variable

Included in
Analytic Sample

Excluded from
Analytic Sample

Pvalue

N
Maternal age (years)
Married
≥ High school
Currently employed
Pre-pregnancy BMI (kg/
m2)
Parity
Gestational age at time of
study visit (weeks)
Smoked during pregnancy
Alcohol consumption in
last month
Log hs-CRPb
Log IL-6c
Log IL-10c
Log IL-1βcc
Log TNF-αc
IL-6/IL-10 ratio
IL-10/TNF-α ratio
First trimester BTEX
exposure (μg/m3)d
Mid-pregnancy BTEX
exposure (μg/m3)e

140
26.3 ± 5.8
29 (20.7 %)
116 (82.9 %)
62 (44.3 %)
29.5 ± 7.7

58a
27.2 ± 6.3
21 (36.2 %)
55 (94.8 %)
40 (69.0 %)
28.5 ± 7.3

0.366
0.022
0.026
0.002
0.395

1.1 ± 1.2
21.3 ± 3.7

0.7 ± 0.9
20.7 ± 3.8

0.012
0.289

12 (8.6 %)
6 (4.3 %)

2 (3.5 %)
1 (1.7 %)

0.241
0.676

1.19 ± 1.08
1.28 ± 0.56
0.62 ± 0.37
− 0.45 ± 0.57
1.71 ± 0.65
2.22 ± 1.12
0.43 ± 0.32
7.9 ± 2.3

1.12 ± 0.76
1.14 ± 0.62
0.59 ± 0.29
− 0.33 ± 0.58
1.78 ± 0.68
2.04 ± 1.29
0.38 ± 0.25

0.635
0.160
0.564
0.194
0.484
0.368
0.248

8.0 ± 1.8

BMI, body mass index; hs-CRP, high-sensitivity C-reactive protein; IL, inter
leukin; TNF-α, tumor necrosis factor-α; BTEX, benzene, toluene, ethylbenzene,
xylene.
Data are mean ± standard deviation or N (%).
Bold font indicates variable with P < 0.05.
a
N = 56 for inflammatory biomarkers.
b
On raw scale, in units of mg/L.
c
On raw scale, in units of pg/mL.
d
First trimester BTEX exposure is the average exposure during the first
trimester of pregnancy.
e
Mid-pregnancy BTEX exposure is the average exposure from the start of
pregnancy through the time of inflammatory biomarker measurement.

3. Results
Table 1 presents the comparison of the 140 women included in the
analysis to the 58 women excluded from the analysis. While there was no
difference in any inflammatory biomarker (all P > 0.160), women
excluded from the analysis were statistically significantly more likely to
be married, to have at least a high school education, to be currently
employed, and to have a lower mean parity. The mean gestational age at
the time of inflammatory biomarker measurement was 21.3 ± 3.7
weeks. The mean BTEX exposure in the first trimester was 7.9 ± 2.3 μg/
m3 and in mid-pregnancy was 8.0 ± 1.8 μg/m3 (Table 1); these were
statistically significantly correlated (r = 0.77, P < 0.001). Only 14
women (10 %) experienced PTB; neither BTEX estimate was associated
with PTB (all P > 0.501).
The distribution of each mid-pregnancy inflammatory biomarker
and ratio by dichotomized first trimester BTEX exposure is presented in
Fig. 1. Women with higher first trimester BTEX exposure had statisti
cally significant lower hs-CRP (P = 0.022) and IL-10 to TNF-α ratio
(P = 0.001) and higher TNF-α (P < 0.001) and IL-1β (P = 0.028)
compared to women with lower first trimester BTEX exposure; there
were no differences in IL-6, IL-10, or the IL-6 to IL-10 ratio (Fig. 1; all
P > 0.411). After adjusting for maternal age, pre-pregnancy BMI, high
school education, and gestational age at inflammatory biomarker mea
surement, first trimester BTEX was statistically significantly positively
associated with log-transformed IL-1β (P = 0.014) and log-transformed
TNF-α (P = 0.006); for every 1-unit increase in first trimester BTEX,
there was an expected mean increase in log-transformed IL-1β of
0.05 ± 0.02 units and in log-transformed TNF-α of 0.07 ± 0.02 units in
mid-pregnancy (Table 2). There was no association of first trimester
BTEX and hs-CRP, IL-6, IL-10, the IL-6 to IL-10 ratio, or the IL-10 to TNFα ratio (Table 2).
The distribution of each inflammatory biomarker and ratio by

dichotomized mid-pregnancy BTEX exposure is presented in Fig. 2; there
were no statistically significant differences in any inflammatory
biomarker or ratio between women in the higher vs. lower midpregnancy BTEX exposure category (all P > 0.054). After adjusting for
maternal age, pre-pregnancy BMI, high school education, and gesta
tional age at inflammatory biomarker measurement, for every 1-unit
increase in mid-pregnancy BTEX, there was a mean increase in log IL1β of 0.06 ± 0.03 units (P = 0.027). There was no association of midpregnancy BTEX exposure and hs-CRP, IL-6, IL-10, TNF-α, the IL-6 to
IL-10 ratio, and the IL-10 to TNF-α ratio after covariate adjustment
(Table 2).
3.1. Benzene (PMA) and Toluene (BMA) metabolites
In the subset of 25 women with metabolite data, 8 (32 %) women had
detectable PMA and 21 (84 %) had detectable BMA. Although not sta
tistically significant (Table 3; all P > 0.51), women with detectable BMA
had higher first trimester BTEX exposure levels compared to women
without detectable BMA and women with detectable PMA had higher
first trimester and mid-pregnancy BTEX exposures compared to women
without detectable PMA. Women with detectable BMA had statistically
significant higher mean log IL-6 and log IL-1β levels compared to women
without detectable BMA (Table 3; both P = 0.04). There was no other
association of BMA with any inflammatory biomarker or with PMA and
any inflammatory biomarker (Table 3).

3
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Fig. 1. Distribution of each log-transformed inflammatory biomarker (or biomarker ratio) by first trimester BTEX exposure (defined as high exposure if above the
median and low exposure if below the median; median = 7.30 μg/m3). First trimester BTEX exposure is the average exposure during the first trimester of pregnancy.
BTEX, benzene, toluene, ethylbenzene, xylene; CRP, C-reactive protein; IL, interleukin; TNF-α, tumor necrosis factor-α.
Table 2
Association of first trimester BTEX exposure and mid-pregnancy BTEX exposure with mid-pregnancy inflammatory biomarkers.
Variable
First trimester BTEX exposure (μg/m3)a
Unadjusted
Adjusted for maternal age, prepregnancy BMI, and high school
education
Adjusted for maternal age, prepregnancy BMI, high school
education, and GA at inflammatory
biomarker measurement
Mid-pregnancy BTEX exposure (μg/m3)b
Unadjusted
Adjusted for maternal age, prepregnancy BMI, and high school
education
Adjusted for maternal age, prepregnancy BMI, high school
education, and GA at inflammatory
biomarker measurement

Log hs-CRP

Log IL-6

Log IL-10

Log IL-1β

Log TNF-α

IL-6/IL-10

IL-10/TNF-α

β±se

β±se

β±se

β±se

β±se

β±se

β±se

(P-value)

(P-value)

(P-value)

(P-value)

(P-value)

(P-value)

(P-value)

− 0.04 ± 0.04
(p = 0.302)
− 0.02 ± 0.03
(p = 0.494)

0.02 ± 0.02
(p = 0.295)
0.03 ± 0.02
(p = 0.154)

0.02 ± 0.01
(p = 0.197)
0.02 ± 0.01
(p = 0.184)

0.05 ± 0.02
(p ¼ 0.020)
0.05 ± 0.02
(p ¼ 0.020)

0.06 ± 0.02
(p ¼ 0.009)
0.06 ± 0.02
(p ¼ 0.008)

0.02 ± 0.04
(p = 0.667)
0.03 ± 0.04
(p = 0.458)

− 0.0 ± 0.01
(p = 0.719)
− 0.00 ± 0.01
(p = 0.737)

− 0.02 ± 0.03
(p = 0.609)

0.03 ± 0.02
(p = 0.135)

0.02 ± 0.01
(p = 0.206)

0.05 ± 0.02
(p ¼ 0.014)

0.07 ± 0.02
(p ¼ 0.006)

0.04 ± 0.04
(p = 0.372)

− 0.01 ± 0.01
(p = 0.656)

¡0.11
± 0.05
(p ¼ 0.033)
− 0.07 ± 0.04
(p = 0.110)

− 0.0 ± 0.03
(p = 0.900)

0.04 ± 0.02
(p ¼ 0.044)

0.05 ± 0.03
(p = 0.065)

0.04 ± 0.03
(p = 0.190)

− 0.06 ± 0.05
(p = 0.285)

0.01 ± 0.02
(p = 0.552)

0.01 ± 0.03
(p = 0.787)

0.04 ± 0.02
(p ¼ 0.043)

0.05 ± 0.03
(p ¼ 0.049)

0.04 ± 0.03
(0.166)

− 0.03 ± 0.05
(p = 0.496)

0.01 ± 0.02
(p = 0.525)

− 0.06 ± 0.04
(p = 0.189)

0.01 ± 0.03
(p = 0.700)

0.04 ± 0.02
(p = 0.052)

0.06 ± 0.03
(p ¼ 0.027)

0.05 ± 0.03
(p = 0.115)

− 0.02 ± 0.05
(p = 0.661)

0.01 ± 0.02
(p = 0.647)

β, parameter estimate; se, standard error; BMI, body mass index; hs-CRP, high-sensitivity C-reactive protein; IL, interleukin; TNF-α, tumor necrosis factor-α; BTEX,
benzene, toluene, ethylbenzene, xylene; GA, gestational age.
Bold font indicates variable with P < 0.05.
a
First trimester BTEX exposure is the average exposure during the first trimester of pregnancy.
b
Mid-pregnancy BTEX exposure is the average exposure from the start of pregnancy through the time of inflammatory biomarker measurement.

4. Discussion

the most consistent evidence was for an association of BTEX exposure
with higher levels of mid-pregnancy IL-1β. This finding is supported by
evidence both from estimated ambient BTEX exposure and from the
toluene metabolite BMA in maternal plasma. We recently showed that
higher ambient BTEX exposure in pregnancy is associated with elevated

We found higher estimated BTEX exposure was associated with
higher levels of the inflammatory biomarkers IL-1β and TNF-α in midpregnancy in a sample of pregnant African-American women. Overall,
4
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Fig. 2. Distribution of each log-transformed
inflammatory biomarker (or biomarker ratio)
by mid-pregnancy BTEX exposure (defined as
high exposure if above the median and low
exposure
if
below
the
median;
median = 7.98 μg/m3). Mid-pregnancy BTEX
exposure is the average exposure from the start
of pregnancy through the time of inflammatory
biomarker measurement. BTEX, benzene,
toluene, ethylbenzene, xylene; CRP, C-reactive
protein; IL, interleukin; TNF-α, tumor necrosis
factor-α.

Table 3
Pilot analysis comparing ambient BTEX levels (first trimester and mid-pregnancy) and inflammatory biomarkers by detectable vs. non-detectable benzene (PMA) and
toluene (BMA) metabolites.
PMA (benzene)

BMA (toluene)

Measure

Detectable

Non-detectable

N
First trimester BTEX (μg/m3)a
Mid-pregnancy BTEX (μg/m3)b
Log hs-CRP
Log IL-6
Log IL-10
Log IL-1β
Log TNF-α
IL-6/IL-10
IL-10/TNF-α

8
7.44 ± 1.19
7.44 ± 1.44
1.14 ± 0.80
1.41 ± 0.33
0.55 ± 0.27
− 0.58 ± 0.49
1.84 ± 0.74
2.44 ± 0.79
0.34 ± 0.24

17
7.12 ± 1.33
6.93 ± 1.49
0.91 ± 0.98
1.27 ± 0.72
0.37 ± 0.31
− 0.35 ± 0.49
1.85 ± 0.79
2.92 ± 1.85
0.30 ± 0.21

P-value

Detectable

Non-detectable

P-value

0.67
0.58
0.76
0.87
0.13
0.28
0.87
0.63
0.63

21
7.31 ± 1.30
7.01 ± 1.30
1.05 ± 0.82
1.43 ± 0.58
0.50 ± 0.18
¡0.33 ± 0.47
1.95 ± 0.78
2.92 ± 1.67
0.30 ± 0.20

4
6.79 ± 1.16
7.44 ± 2.28
0.62 ± 1.41
0.71 ± 0.57
0.08 ± 0.56
¡0.84 ± 0.42
1.35 ± 0.51
2.11 ± 1.27
0.38 ± 0.39

0.51
0.67
0.48
0.04
0.11
0.04
0.15
0.31
0.61

BTEX, benzene, toluene, ethylbenzene, xylene; hs-CRP, high-sensitivity C-reactive protein; IL, interleukin; TNF-α, tumor necrosis factor-α.
Data are mean ± standard deviation.
Bold font indicates variable with P < 0.05.
a
First trimester BTEX exposure is the average exposure during the first trimester of pregnancy.
b
Mid-pregnancy BTEX exposure is the average exposure from the start of pregnancy through the time of inflammatory biomarker measurement.

risk of PTB in Detroit (Cassidy-Bushrow et al., 2020), thus the current
study suggests that inflammatory mechanisms may be involved in the
association between BTEX exposure and PTB.
Exposure to BTEX (or its components) is associated with alterations
in inflammatory biomarkers; however, most evidence comes from
studies in men and non-pregnant women. In the Gulf Long-Term Followup study (GuLF), benzene and toluene, measured in blood, were posi
tively associated with IL-1β levels in obese men but inversely associated
with IL-1β levels in non-obese men (Werder et al., 2020). In our cohort,
where the majority of women were overweight (26.4 %) or obese (41.6
%) pre-pregnancy (Cassidy-Bushrow et al., 2012), we also found evi
dence that higher ambient BTEX exposure, as well as having detectable
levels of a toluene metabolite, was associated with higher IL-1β levels.
Evidence supporting a role of BTEX or its constituents with TNF-α is
mixed. In a study of adults in Iran, residing in areas with higher levels of
the mixture benzene, toluene, xylene and styrene was associated with
higher TNF-α levels (Samadi et al., 2019). In contrast, in men in the GulF
study, neither benzene, toluene or ethylbenzene were associated with

TNF-α (Werder et al., 2020).
Normal pregnancy is characterized by changes in the maternal im
mune system (Mor et al., 2011, 2017). Atypical alterations in inflam
matory biomarkers are associated with poorer birth outcomes. In a study
of 495 women in Malaysia, plasma IL-1β at the time of labor was higher
in women who delivered PTB (Langmia et al., 2016). In the Pregnancy
Outcomes and Community Health study, conducted in Michigan, higher
mid-pregnancy IL-1β but not TNF-α was associated with greater odds of
PTB (Gargano et al., 2008). In data from the Perinatal Research Center in
Nashville, TN, in African-American women both IL-1β and TNF-α in
plasma at the time of labor were statistically significantly higher in those
with PTB, whereas in Caucasian women, there was no statistically sig
nificant difference by PTB status in these biomarkers (Brou et al., 2012).
In women with a history of previous PTB, higher second trimester serum
TNF-α is associated with increased risk of recurrent PTB (Vogel et al.,
2007). In a review by Pandey et al. (2017), TNF-α is described as a
pro-inflammatory cytokine that promotes production of metal
loproteinases, which in turn can weaken fetal membrane strength and
5
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block progesterone release, each of which are associated with PTB.
IL-1β, which is the inflammatory biomarker most consistently associated
with BTEX in the current study, is also a pro-inflammatory cytokine;
higher levels of IL-1β may stimulate prostaglandin secretion and myo
metrium contraction, which can lead to PTB (Equils et al., 2020). BTEX
may influence the risk of PTB by altering inflammatory cytokines that
have a potential biologic role in PTB. Importantly, the biomarkers in the
current study were measured during mid-pregnancy, prior to onset of
labor. Many of the aforementioned studies measured biomarkers at
parturition and differences in inflammatory biomarkers during labor
may relate more strongly to differences in parturition of a preterm versus
term infant and could account for discrepancies in findings.
Mechanistically, BTEX may lead to altered systemic inflammation via
activation of innate immune system cells (including Natural Killer [NK]
cells) (Guo et al., 2020); these cells help maintain a normal tissue
microenvironment by protecting against pathogens and irritants. Once
innate immune system cells are activated, they differentiate and produce
a wide range of inflammatory cytokines to recruit and activate addi
tional immune cells, thereby amplifying the inflammatory response until
the foreign stimuli is removed. However, previous studies have largely
focused on the toxic effects of benzene, rather than BTEX as a whole. As
described in the review by Bahadar et al. (2014), benzene exposure can
negatively impact numerous organ systems, including the hematopoi
etic, immune and reproductive systems, with the toxicity occurring via
mechanisms including formation of reactive oxygen species, oxidative
DNA damage, DNA methylation changes, and chromosomal abnormal
ities. Reactive oxygen species, for example, are produced by NK cells in
response to foreign stimuli and can further enhance the inflammatory
process by promoting cell death of infected or damaged cells (Hensley
et al., 2000). A better understanding of the molecular mechanisms by
which BTEX exposure may lead to increased inflammation is needed.
We found some differences in associations comparing first trimester
BTEX exposure to mid-pregnancy BTEX exposure with the inflammatory
biomarkers. After adjusting for selected risk factors, ambient BTEX
exposure level in the first trimester was significantly associated with IL1β and TNF-α while mid-pregnancy BTEX exposure was only associated
with IL-1β. In the current study, data on inflammation was available
only at a single time point obtained during the second trimester; in
flammatory biomarker levels change over pregnancy (Ferguson et al.,
2014), thus we may be missing important time points of measurement
and interactions of these biomarkers. Future studies with additional
timed measurements of BTEX exposure and inflammatory biomarkers
are needed to better understand temporal relationships.
We used maternal address reported at the time of inflammatory
biomarker measurement to estimate BTEX exposure. Change in resi
dence and lack of accounting for mother’s work or other addresses may
result in exposure misclassification. Further, indoor BTEX levels can be
greater than outdoor levels (Minciullo et al., 2014), thus estimates based
on outdoor levels may underestimate true exposure. We conducted a
pilot study measuring two BTEX metabolites in maternal plasma, PMA
and BMA, to capture a measure of direct, rather than estimated, BTEX
exposure. While urine is the preferred matrix for measuring BTEX me
tabolites, we did not have available urine samples. Although not sta
tistically significant, women with detectable PMA had higher estimated
BTEX exposure levels (both in the first trimester and mid-pregnancy)
than women without detectable PMA; women with detectable BMA
also had higher estimated first trimester BTEX exposure compared to
women without detectable BMA. This is in contrast to a study of 61
women in Cape Town, South Africa, where personal BTEX exposure (and
the individual BTEX constituents) was measured over a 7-day period
using compact passive diffusion samplers and PMA and BMA measured
in urine; higher personal toluene exposure was not associated with BMA
(r = 0.12, P > 0.05) but was statistically significantly and inversely
associated with PMA (r = -0.22, P < 0.05) and personal benzene expo
sure was not associated with PMA (r = 0.01, P > 0.05) or BMA (r =
-0.07, P > 0.05) (Everson et al., 2019). Given our small sample size

(n = 25 with metabolite and ambient BTEX exposure data), we may be
underpowered. Women with detectable BMA also had higher levels of
IL-6 and IL-1β. Due to the small sample size, we did not adjust for po
tential confounders; however, these results, together with the consistent
evidence that both first trimester and mid-pregnancy estimated BTEX
exposure were also associated with IL-1β, provide further support that
maternal BTEX exposure is associated with inflammation. Future studies
that capture additional address information and measure indoor expo
sure levels and direct exposure to environmental contaminants (e.g.,
additional metabolites of BTEX) are needed to better understand the
association of BTEX and inflammation in pregnancy.
4.1. Strengths and limitations
Our pollution models were only applicable to women residing within
Detroit; thus only 69.0 % of the original cohort was included in the
analysis. Although there were some expected socioeconomic differences
in women included vs. excluded from the analytic sample, there was no
difference in inflammatory biomarker levels. Our results may not be
generalizable to women of other races or to women living outside of
major urban cities. While the current study only measured circulating/
systemic markers of inflammation, it is important to note that the
placenta, a key player in preterm labor, is a source of inflammatory
markers in maternal circulation. Nonetheless, measures of in utero
inflammation, such as in cervicovaginal or amniotic fluid may be a more
specific marker of inflammation relevant to PTB (Buxton et al., 2019),
but, these require more invasive approaches. Future studies should
consider measurements of systemic inflammation with confirmation of
in utero or histologic inflammation in a subset of participants. As only 14
women in the analytic sample had a PTB, we were unable to conduct a
mediation analysis; future studies examining the potential mediating
effect of inflammation between BTEX exposure and PTB are needed.
Strengths of the current study include that our estimates of ambient
air pollution exposure have uniquely high spatial and temporal resolu
tion capable of representing exposure variability during pregnancy.
Such data may be critical to more accurately quantify neighborhood
scale and seasonally varying exposure levels (Ross et al., 2013). We were
able to explore potential confounders, including maternal education and
pre-pregnancy
BMI.
Importantly,
this
study
focuses
on
African-American pregnant women, a group at highest risk for PTB
(Martin et al., 2019).
4.2. Conclusion
African-American women are disproportionately more likely to
experience adverse birth outcomes (Martin et al., 2019) and be exposed
to environmental toxicants (Burris et al., 2011; Burris and Hacker,
2017). Our study showing ambient BTEX exposure is associated with
mid-pregnancy inflammation may lead to future studies of environ
mental factors and potential mechanisms driving racial disparities in
women and children’s health.
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